ScreenerHero
0RU5Oncoinvent ASA
LSE · GB · Healthcare · Biotechnology · oncoinvent.com
84.50NOK-4.39%Mkt Cap: —P/E: —

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap—
Enterprise Value19.73M $
Revenue (TTM)2.62M $
Gross Profit2.62M $
Net Income (TTM)-14.50M $
Revenue/Share2.117 USD
Last Price84.50 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees44
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINNO0010650013
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.41
EV/Revenue7.52
P/S—
P/B2.70
EPS (TTM)-3.50
EPS (Forward)—
52W Range
84.500% of range88.38
52W High88.38 NOK
52W Low84.50 NOK
Profitability
Gross Margin100.00%
Oper. Margin-659.95%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-121.79%
ROA-52.64%
Growth
Revenue Growth100.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.14M $
CapEx (TTM)—
FCF Margin-303.52%
FCF Yield—
Net Debt-16.27M $
Net Debt/EBITDA1.16
Balance Sheet
Debt/Equity2.43
Current Ratio3.23
Quick Ratio3.20
Book Value/Sh32.67 NOK
Cash/Share39.66 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.01:1
Split DateMay 30, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.71M
Float3.00M
Insiders23.07%
Institutions38.70%
Technical
SMA 500.2624 (+32101.1%)
SMA 2000.5130 (+16370.7%)
Beta—
S&P 52W Chg20.80%
Avg Vol (30d)933
Avg Vol (10d)133.58K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—